LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)
Close on Nov 18, 2026Market cap $59.59MP/E –Yield –
Lensar operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lensar's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.29M. For fiscal 2025 it was -$14.83M. The highest annual figure on record is -$2.28M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.83M | – |
| FY2024 | Dec 31, 2024 | -$2.28M | – |
| FY2023 | Dec 31, 2023 | -$9.66M | – |
| FY2022 | Dec 31, 2022 | -$14.86M | – |
| FY2021 | Dec 31, 2021 | -$8.97M | – |
| FY2020 | Dec 31, 2020 | -$13.79M | – |
| FY2019 | Dec 31, 2019 | -$12.59M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$127.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.27M | – |
| Q4 FY2025 | Dec 31, 2025 | $618.00K | -83.1% |
| Q3 FY2025 | Sep 30, 2025 | -$3.51M | -211.4% |
| Q2 FY2025 | Jun 30, 2025 | -$5.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.94M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.66M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$480.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$339.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.14M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.76M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.70M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.79M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.61M | – |
| Q4 FY2021 | Dec 31, 2021 | -$739.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.15M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.00M | – |
| Q3 FY2020 | Sep 30, 2020 | -$55.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.78M | – |
See a number that looks wrong?